Back to Results
First PageMeta Content
Cancer treatments / Ipilimumab / Immunotherapy / Skin cancer / Expanded access / Wolfram Samlowski / Medicine / Oncology / Melanoma


MRA Hails Launch of Expanded Access Program in Advanced Melanoma Washington, DC, July 11, 2014 – The Melanoma Research Alliance (MRA) hails the launch of an Expanded Access Program (EAP) that allows late-stage melanoma
Add to Reading List

Document Date: 2014-07-11 14:06:26

Open Document

File Size: 82,11 KB

Share Result on Facebook

City

Washington / DC / /

Company

Anreder & Company / /

Currency

USD / /

/

Facility

Milken Institute / /

IndustryTerm

pharmaceutical company leaders / /

MedicalCondition

grant-giving disease / metastatic disease / melanoma / late-stage melanoma / skin cancer / advanced melanoma / metastatic melanoma / /

MedicalTreatment

immunotherapy / /

Organization

Melanoma Research Alliance / Milken Institute / Melanoma Research Alliance MRA / U.S. Food and Drug Administration / /

Person

Leon Black / Wendy Selig / Michael Wichman / Debra Black / /

/

Position

Governor / president and CEO / /

Product

PD1 / /

ProgrammingLanguage

DC / /

Technology

Genetic Engineering / Biotechnology / /

URL

www.CureMelanoma.org / /

SocialTag